Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Zepbound Cost Without Insurance in 2026: Complete Price Guide
articleThe Zepbound KwikPen list price is $1,086.37 a month without insurance. The LillyDirect Self Pay Journey Program (launched February 2026) brings cash-pay vials down to $299 for 2.5mg, $399 for 5mg, and $449 for every dose from 7.5mg to 15mg when you refill within 45 days. This guide covers Zepbound pricing only, with no Mounjaro overlap.
Zepbound GoodRx vs Savings Card vs LillyDirect: 2026 Prices
articleLilly runs two Zepbound savings cards, not one, and both carry the same $299 to $449 KwikPen dose ladder. This guide prices every route by eligibility class, names the device and dose behind each figure, and shows why GoodRx's $299 headline is the ladder's bottom rung.
Zepbound Savings Card: How to Get $25/Month (2026 Guide)
articlePrescribed Zepbound for weight management? This guide covers the savings card eligibility tiers, the exact per-fill and annual caps, how to enroll, why the card gets rejected at the pharmacy counter, and what to do if it does not apply to you.